CHF3381, a novel antinociceptive agent, attenuates capsaicin-induced pain in rats

In conclusion, CHF3381 had full efficacy for all the capsaicin-induced pain parameters tested, suggesting that CHF3381 may have a therapeutic utility in the management of pain states involving central sensitisation.